166 related articles for article (PubMed ID: 22646136)
1. Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus.
Hawro T; Maurer M; Sysa-Jędrzejowska A; Woźniacka A
Br J Dermatol; 2013 Jan; 168(1):213-5. PubMed ID: 22646136
[No Abstract] [Full Text] [Related]
2. Cutaneous manifestations of antiphospholipid syndrome.
Gomez-Flores M; Herrera-Argaez G; Vazquez-Martinez O; Herz-Ruelas M; Ocampo-Candiani J; Villarreal-Martinez A; Galarza-Delgado DA; Hernandez-Galarza I; Chavez-Alvarez S
Lupus; 2021 Apr; 30(4):541-548. PubMed ID: 33583236
[TBL] [Abstract][Full Text] [Related]
3. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539
[TBL] [Abstract][Full Text] [Related]
4. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
[TBL] [Abstract][Full Text] [Related]
5. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous expressions of antiphospholipid syndromes.
Eng AM
Semin Thromb Hemost; 1994; 20(1):71-8. PubMed ID: 8059236
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in systemic lupus erythematosus and Sneddon's syndrome.
Söhngen D; Wehmeier A; Specker C; Schneider W
Semin Thromb Hemost; 1994; 20(1):55-63. PubMed ID: 8059234
[No Abstract] [Full Text] [Related]
8. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.
Francès C; Niang S; Laffitte E; Pelletier Fl; Costedoat N; Piette JC
Arthritis Rheum; 2005 Jun; 52(6):1785-93. PubMed ID: 15934071
[TBL] [Abstract][Full Text] [Related]
9. [Dermatologic manifestations of the antiphospholipid syndrome].
Francès C; Barete S; Soria A
Rev Med Interne; 2012 Apr; 33(4):200-5. PubMed ID: 22078802
[TBL] [Abstract][Full Text] [Related]
10. Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies.
Sangle S; D'Cruz DP; Hughes GR
Ann Rheum Dis; 2005 Jan; 64(1):147-8. PubMed ID: 15608315
[TBL] [Abstract][Full Text] [Related]
11. Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: seronegative antiphospholipid-like syndrome.
Duval A; Darnige L; Glowacki F; Copin MC; Martin De Lassalle E; Delaporte E; Auxenfants E
J Am Acad Dermatol; 2009 Dec; 61(6):1076-8. PubMed ID: 19646781
[TBL] [Abstract][Full Text] [Related]
12. Dermatological manifestations of Hughes' antiphospholipid antibody syndrome.
Frances C
Lupus; 2010 Aug; 19(9):1071-7. PubMed ID: 20693200
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
14. Lupoid sclerosis: what is the role of antiphospholipid antibodies?
Lima I; Melo A; Brandi IV; Costa O; Santiago M
J Clin Rheumatol; 2007 Apr; 13(2):85-6. PubMed ID: 17414536
[TBL] [Abstract][Full Text] [Related]
15. [Neuro-ophthalmologic aspects in antiphospholipid syndrome].
Roşca T; Bontaş E; Bartoş D
Oftalmologia; 2004; 48(2):65-70. PubMed ID: 15341103
[TBL] [Abstract][Full Text] [Related]
16. Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies.
Sangle SR; Jan W; Lau IS; Bennett AN; Hughes GR; D'Cruz DP
Clin Exp Rheumatol; 2006; 24(3):349. PubMed ID: 16870110
[No Abstract] [Full Text] [Related]
17. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus.
Asherson RA; Lioté F; Page B; Meyer O; Buchanan N; Khamashta MA; Jungers P; Hughes GR
J Rheumatol; 1993 Feb; 20(2):284-8. PubMed ID: 8474066
[TBL] [Abstract][Full Text] [Related]
18. Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?
Kontic M; Stojanovich L; Mijailović-Ivković M; Velinović M; Srnka J; Zdravkovic M
Clin Exp Rheumatol; 2018; 36(1):56-61. PubMed ID: 28770705
[TBL] [Abstract][Full Text] [Related]
19. [Immunopathology of the antiphospholipid syndrome].
Stojanović Lj; Alekbergova Z; Kalasnikova Lj; Nasonov E; Manujlova L; Sokolov V; Stanić M
Srp Arh Celok Lek; 1994; 122 Suppl 1():53-6. PubMed ID: 18173188
[TBL] [Abstract][Full Text] [Related]
20. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
Kriseman YL; Nash JW; Hsu S
J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
